NCT00618839View on ClinicalTrials.gov

StrataGraft™ Skin Tissue (Human Donor Skin) In The Surgical Management Of Complex Skin Defects

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Third Degree BurnBurnsWound InfectionDegloving Injury
Interventions
BIOLOGICAL

StrataGraft Skin Tissue

StrataGraft™ skin tissue is provided as a suturable circular patch of stratified epithelial tissue composed of a living dermal matrix (containing dermal fibroblasts) overlaid with human epidermal cells (NIKS™ cells).

PROCEDURE

Cadaver allograft

The standard of care for temporary coverage of full thickness skin defects is coverage with cadaver allograft until the wound can be autografted.

Trial Locations (2)

53792

University of Wisconsin-Hospital and Clinics, Madison

85008

Arizona Burn & Trauma Center, Phoenix

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Stratatech, a Mallinckrodt Company

INDUSTRY

NCT00618839 - StrataGraft™ Skin Tissue (Human Donor Skin) In The Surgical Management Of Complex Skin Defects | Biotech Hunter | Biotech Hunter